2nd Annual Chronic Kidney Disease Drug Development Summit (description)


Address:200 Stuart Street Boston, Massachusetts, United States of America 02116
Event dates:5/6/2019 - 5/8/2019 (This event has already taken place)
Event web site:
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate 2nd Annual Chronic Kidney Disease Drug Development Summit


Topics to be Covered:

  • George Bakris, University of Chicago, Vlado Perkovic, The George Institute Australia, Matthias Kretzler, University of Michigan, Jyothis George, Boehringer Ingelheim, Pernille B. Laerkegaard Hansen, AstraZeneca, Matthew Breyer, Janssen Research & Development, Lori Gowen Morton, Regeneron Pharmaceuticals, Curtis Rambaran, Daiichi Sankyo, Fabio Dorigotti, Vifor Pharma, Radko Komers, Retrophin, Colin Meyer, Reata Pharmaceuticals, Carol Moreno Quinn, AstraZeneca, Bergur Stefansson, AstraZeneca, Barbara Gillespie, University of North Carolina, Melissa West, American Society of Nephrology, Anna Greka, Brigham and Women’s Hospital, John Brennan, AbbVie, Gigi Shafai, Akebia Therapeutics, Rahul Kakkar, Corvidia Therapeutics, Harry Alcorn, Diamedica, Dario Lemos, Brigham and Women's Hospital, Steven Coca, Mount Sinai, Darren Kelly, Certa Therapeutics, Guangping Gao, University of Massachusetts Medical School, Benjamin Freedman, University of Washington, Nichole Jefferson, KHI Patient Family Partnership Council, Tim Johnson, UCB, Lesley Inker, Tufts University School of Medicine
  • Science
  • Health and Medicine
  • Pharmaceuticals
Organizer phone:
Offering type:Conference
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:Hanson Wade
Est. # of exhibitors:
Currency:US Dollars
CE Credits:
Organizer URL


The 2nd Chronic Kidney Disease Drug Development (CKD3) focuses exclusively on overcoming challenges limiting the development of more efficacious and disease-modifying drugs against diabetic nephropathy, genetic and glomerular kidney disease.

Incorporating insights from 25+ industry leading speakers, this uniquely specific forum assesses key clinical and translational hurdles and the hottest emerging research necessary to achieve the potential of next-generation CKD drugs.

Join 80+ of your colleagues to accelerate the development of SGLT-2 inhibitors, antagonists of renal fibrosis and more, and advance the clinical validity and commercial viability for next-generation standards of care.


Time: 8:00 am to 5:00 pm

Registration Fee Details:

Conference + 2 Workshops: USD 4097.0
Conference + 1 Workshop: USD 3498.0
Conference Only: USD 2899.0
Workshop Only: USD 699.0

Other items that tuition includes:

Travel and hotel arrangements:

Contact Person:Georgina FitzGerald
Organizer State/Province: (Outside US)
Organizer CountryData not provided
Structural makeupData not provided
Host Sponsor; Other SponsorsHanson Wade
Event Site/VenueRevere Hotel Boston Common
Event sold out?No
Multiple locations or dates?No
Statistics available for most recent event held in:NA
Average number in event attendance of:
Number in attendance of:
Target BoundariesLocal
Is Registration contact information the same as Organizer Contact above?Yes
Web Page
Can one register for your CE on your web site?NA
Can registration be made by snail (regular) mail?Yes
Online housing reservations: 
Do you have additional written or AV materials for sale?No
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?No
Will there be shuttle service available?NA
Additional notes:


Sign In/Sign Out
About Us
Contact Us